CYTK
Cytokinetics Inc
65.80$
-2.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -95.5% | 17.0% | 34.8% | -761.2% | -321.3% | -338.3% | 16.0% | -202.4% | -316.7% | -5,502.4% | -2,143.0% | -579.3% | |
| 1.0% | 2.1% | 0.7% | 14.4% | 3.9% | 4.8% | 3.3% | 3.2% | 6.1% | 157.9% | 51.6% | 11.5% | |
| 7.1% | 15.9% | 6.7% | 67.5% | 31.0% | 40.0% | 31.6% | 38.1% | 50.6% | 957.0% | 529.6% | 127.5% | |
| 7.1% | 15.9% | 7.2% | 67.0% | 31.0% | 43.5% | 42.4% | 48.2% | 83.1% | – | – | – | |
| -72.5% | 130.0% | 11.4% | 3.6% | -72.8% | -14.5% | 159.6% | 12.0% | -26.1% | 41.0% | 193.0% | -40.5% | |
| 2.4% | 2.0% | 1.5% | 21.5% | 2.8% | 9.7% | 19.8% | 69.4% | 12.0% | 18.8% | 21.1% | 28.2% | |
| -8.6% | 56.1% | -48.9% | -492.4% | 16.3% | -278.1% | -352.0% | -209.8% | -277.1% | 3,177.3% | -2,993.9% | 18.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | 245.1% | – | – | |
| 104.3% | 31.5% | 1.8% | 946.1% | 10.3% | 140.0% | -4.0% | -6.3% | 18.5% | -139.7% | 287.0% | – | |
| 31.7% | 52.0% | 14.1% | 9.4% | 31.4% | 6.4% | 599.5% | 475.2% | 500.6% | -11.4% | -52.1% | 358.9% | |
| 104.3% | 83.4% | 15.9% | 1,690.0% | 41.7% | 594.7% | 419.4% | 454.3% | 545.7% | 2,939.1% | 5,037.4% | 595.7% | |
| 0.1% | 156.5% | 1.7% | 436.4% | -263.3% | -21.7% | 83.4% | 42.1% | -48.1% | 613.8% | -98.3% | 34.5% | |
| -97.9% | 15.1% | 33.3% | -782.7% | -324.1% | -348.1% | -3.8% | -271.8% | -328.6% | -5,521.2% | -2,164.1% | -607.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.